Intra-abdominal bleeding with hemorrhagic shock: a case of adrenal myelolipoma and review of literature.
Liu HP, Chang WY, Chien ST, Hsu CW, Wu YC, Kung WC, Su CM, Liu PH.
BMC Surg. 2017 Jun 26;17(1):74. doi: 10.1186/s12893-017-0270-6.
PMID:28651560
Incidence and treatment of hepatic artery complications after orthotopic liver transplantation.
Zhao JC, Lu SC, Yan LN, Li B, Wen TF, Zeng Y, Cheng NS, Wang J, Luo Y, Pen YL.
World J Gastroenterol. 2003 Dec;9(12):2853-5. doi: 10.3748/wjg.v9.i12.2853.
PMID:14669351
Safety and efficacy of hyperthermic intraperitoneal chemoperfusion with high-dose oxaliplatin in patients with peritoneal carcinomatosis.
Ceelen WP, Peeters M, Houtmeyers P, Breusegem C, De Somer F, Pattyn P.
Ann Surg Oncol. 2008 Feb;15(2):535-41. doi: 10.1245/s10434-007-9648-5. Epub 2007 Oct 25.
PMID:17960463
Population pharmacokinetics of peritoneal, plasma ultrafiltrated and protein-bound oxaliplatin concentrations in patients with disseminated peritoneal cancer after intraperitoneal hyperthermic chemoperfusion of oxaliplatin following cytoreductive surgery: correlation between oxaliplatin exposure and thrombocytopenia.
Chalret du Rieu Q, White-Koning M, Picaud L, Lochon I, Marsili S, Gladieff L, Chatelut E, Ferron G.
A new animal model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing mice in the treatment of peritoneal carcinomatosis of ovarian origin.
Miailhe G, Arfi A, Mirshahi M, Eveno C, Pocard M, Touboul C.